This Fap2–TIGIT interaction protects both Fn and nearby tumor cells from the killing activity of NK cells, thereby serving as an inhibitor of immune responses in the tumor tissue that in turn further promotes the progress of CRC [56,57]. The gene discussed is TIGIT; the disease is neoplasm.